Volume 11 - Issue 12 - December 2011
Catheter Ablation of Atrial Arrhythmias in the Setting of Congenital Heart Disease
- Wed, 11/30/11 - 12:29pm
- 0 Comments
- 1704 reads
Boston Atrial Fibrillation Symposium: 2012 Preview
- Wed, 11/30/11 - 12:51pm
- 0 Comments
- 1459 reads
Spotlight Interview: Covenant HealthCare
- Wed, 11/30/11 - 1:21pm
- 0 Comments
- 2046 reads
What is the size of the EP lab facility, and what is the mix of staff credentials?
Covenant HealthCare has two dedicated electrophysiology (EP) labs. One lab is completely upgraded to do Carto 3D mapping (Biosense Webster, Inc., a Johnson & Johnson company, Diamond Bar, CA) and laser lead extractions, and the other lab is Carto equipped.
The PINNACLE-AF Outpatient Registry
- Wed, 11/30/11 - 1:29pm
- 0 Comments
- 403 reads
Hybrid OR: Planning for the Metamorphosis
- Wed, 11/30/11 - 4:29pm
- 0 Comments
- 641 reads
In this article, the author discusses the development of a hybrid OR at the University of Michigan, which has three hybrid rooms and plans to add two more: one for the new children’s and women’s hospitals, and another in the Cardiovascular Center.
We have seen it happen before in healthcare as well as in other industries: new technologies that force changes to structure, function and personnel.
Wasteful Medicare Spending, Abusive Medicare Policies, and a Call to Arms
- Wed, 11/30/11 - 4:57pm
- 0 Comments
- 1032 reads
December 23rd is the deadline to make recommendations directly to the Department of Health and Human Services (HHS) regarding which Medicare regulations and policies should be eliminated or revised to remove administrative burden and improve the quality of healthcare.1 I am personally submitting a recommendation that will reconcile coverage guidelines for cardiac rhythm management devices with evidence-based criteria.
Trial Update: The FIX-HF-5B Study
- Wed, 11/30/11 - 5:11pm
- 0 Comments
- 473 reads
Dr. William Abraham talks with EP Lab Digest about a new study evaluating the safety and efficacy of the OPTIMIZER® System (Impulse Dynamics N.V.). Dr. Abraham is the Principal Investigator of the FIX-HF-5B study, Professor of Internal Medicine and Physiology and Cell Biology, Chair of Excellence in Cardiovascular Medicine, Director of the Division of Cardiovascular Medicine, and Deputy Director of the Davis Heart & Lung Research Institute in Columbus, Ohio.
All About the Sudden Cardiac Arrest Association
- Wed, 11/30/11 - 5:36pm
- 0 Comments
- 595 reads
Mechanisms and Application of Cardiac Cryoablation
- Wed, 11/30/11 - 5:53pm
- 0 Comments
- 1298 reads
In this article, the authors review the science behind cryoablation, including cellular physiology and mechanism of ablation, as well as clinical applications for cryoablation such as AF ablation and ablation of certain SVTs.
The effectiveness of cryoablation is demonstrated by long-term studies from diverse clinical applications.1
AF Ablation: Inside or Out?
- Thu, 12/1/11 - 11:53am
- 0 Comments
- 590 reads
A 68-year-old woman with hypertension and medically-refractory, highly symptomatic recurrent persistent atrial fibrillation (AF) underwent a radiofrequency catheter ablation procedure involving wide area circumferential ablation with electrical isolation of the pulmonary veins (PVs). She recovered well, but had three more episodes of persistent AF requiring cardioversion at 3, 4, and 5 months after the procedure. What next?
- « Previous
- | Page 1 of 2 |
- Next »









